KLKecheng Li

Kecheng Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kecheng Li has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Two-phase designs for biomarker studies when disease processes are under intermittent observation

    by Kecheng Li, Richard J Cook

    Multistate models offer an appealing framework for studying the onset and progression of chronic diseases in large cohort studies. Such studies often involve the collection and storage of biospecimens at an initial assessment, and intermittent observation of the disease process at future assessment times. We consider the design of two-phase biomarker studies in such settings where budgetary constraints prohibit assaying all biospecimens. A subsample of individuals is instead chosen to have their biospecimens assayed to facilitate examination of the association between a biomarker of interest and the disease process. Analyses based on likelihood, conditional likelihood, and estimating functions are considered, with the efficiency gains from various subsampling strategies investigated. Pseudo-score residual-dependent sampling strategies are shown to yield highly efficient maximum likelihood estimates of biomarker effects on disease progression. This sampling strategy along with competing methods are empirically studied and applied to a motivating study of the relationship between the HLA-B27 marker and joint damage in patients with psoriatic arthritis.

  • Open Access

    The Design of Large‐Scale Plasma Donation Trials

    by Kecheng Li, Richard J. Cook

    Devices for extracting blood from donors require rigorous evaluation for the safety of donors. Complications arise from the fact that outcomes on successive donations from the same donor are not independent, adverse event rates are extremely rare, and there is substantial heterogeneity in the propensity for donors to donate over time. We develop a statistical framework for the design of a superiority trial and a non‐inferiority trial, aiming to demonstrate the safety of a new donation device compared to the standard one. Historical data on the intensity and heterogeneity of donation across donors, the adverse event rate, and the serial dependence in adverse events provide information on how to plan accrual and follow‐up periods to give the expected number of donors and donations. The analysis is based on a binary donation‐specific outcome modeled with a Poisson approximation (i.e., log link and identity variance function) using generalized estimating equations with a working independence assumption. The historical data enables calculation of the asymptotic robust variance estimate, which is used for planning. The formulae derived are found to provide good control of the type I error rate and statistical power. We illustrate the derivations with application to a plasma donation trial aiming to investigate the safety of a new device, with the outcome being serious hypotensive adverse events.

  • Open Access

    Group sequential analysis of marked point processes: Plasma donation trials

    by Kecheng Li, Richard J Cook

    Plasma donation plays a critical role in modern medicine by providing lifesaving treatments for patients with a wide range of conditions like bleeding disorders, immune deficiencies, and infections. Evaluation of devices used to collect blood plasma from donors is essential to ensure donor safety. We consider the design of plasma donation trials when the goal is to assess the safety of a new device on the response to transfusions compared to the standard device. A unique feature is that the number of donations per donor varies substantially so some individuals contribute more information and others less. The sample size formula is derived to ensure power requirements are met when analyses are based on generalized estimating equations and robust variance estimation. Strategies for interim monitoring based on group sequential designs using alpha spending functions are developed based on a robust covariance matrix for estimates of treatment effect over successive analyses. The design of a plasma donation study is illustrated where the focus is on assessing the safety of a new device with serious hypotensive adverse events as the primary outcome.

  • Use of Generalized Propensity Scores for Assessing Effects of Multiple Exposures

    by Kecheng Li, Tugba Akkaya-Hocagil, Richard J. Cook, Louise M. Ryan, R. Colin Carter, Khue-Dung Dang, Joseph L. Jacobson, Sandra W. Jacobson